1Bergh JGS. Gene amplification in human lung cancer: The myc family genes and other protooncogenes and growth factor genes. Am Rev Respir Dis, 1990,142(1):S20-S26.
2Sugio K,Kishimoto Y,Virmani AK,et al.Kras mutations are a relatively late event in the pathogenesis of lung carcinomas.Cancer Res,1994,54(12):5811-5815.
3Rodenhuis S,Slebos RJ,Boot AJ,et al.Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung.Cancer Res,1988,48(20):5738-5741.
4Cho JY,Kim JH,Lee YH,et al.Correlation between K-ras gene mutation and prognosis of patients with non-small cell lung carcinoma.Cancer.1997,79(1):462-467.
5Graziano SL,Pfeifer AM,Testa JR.Involvement of the RAF1 locus,at band 3p25,in the 3p deletion of small-cell lung cancer.Genes Chromosome Cancer,1991,3(1):283-293.
6Kem JA,Filderman AE.Oncogenes and growth factors in human lung cancer .Clin Chest Med,1993,14(1):31-41.
7Yokota J,Wada M,Shimosato Y,et al.Loss of heterozygosity on chromosomes 3,13 and 17 om small cell carcinoma and on chromosome 3 in adenocarcinoma of the lung.Proc Natl Aced Sci USA,1987,84(25):9252-9256.
8Sozzi G,Miozzo M,Donghi R,et al.Deletions of 17p and p53 mutations in preneoplastic lesions of the lung.Cancer Res,1992,52(23):6079-6082.
9Hung J,Kishimoto Y,Sugio K,et al.Allelespecific chromosome 3p deletions occur at an early stage in the pathogenesis of lung carcinoma.JAMA,1995,15(4):558-563.
10Devereux TR,Taylor JA,Barrett JC.Molecular mechanisms of lung cancer.Chest,1996,109(1):14S-19S.
